X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Newspaper Article (248) 248
Journal Article (226) 226
Publication (23) 23
Book Review (19) 19
Magazine Article (15) 15
Book / eBook (12) 12
Web Resource (6) 6
Patent (5) 5
Book Chapter (2) 2
Conference Proceeding (2) 2
Dissertation (2) 2
Trade Publication Article (2) 2
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (98) 98
index medicus (74) 74
female (42) 42
motion pictures (35) 35
male (30) 30
middle aged (28) 28
canada (27) 27
cost-benefit analysis (27) 27
analysis (24) 24
medicine (24) 24
research (24) 24
adult (23) 23
treatment outcome (22) 22
aged (21) 21
care and treatment (21) 21
clinical trials (21) 21
health aspects (21) 21
health care sciences & services (21) 21
medicine, general & internal (21) 21
studies (21) 21
cost-effectiveness (20) 20
social networks (20) 20
risk (19) 19
economics (18) 18
risk factors (18) 18
health (15) 15
mortality (15) 15
public, environmental & occupational health (15) 15
health policy & services (14) 14
markov chains (14) 14
public health (14) 14
cancer (13) 13
children (13) 13
diagnosis (13) 13
economic evaluation (13) 13
internal medicine (13) 13
quality of life (13) 13
systematic review (13) 13
ticket sales (13) 13
usage (13) 13
intervention (12) 12
meta-analysis (12) 12
ontario (12) 12
population (12) 12
prevention (12) 12
randomized controlled trials as topic (12) 12
abridged index medicus (11) 11
drug therapy (11) 11
medical research (11) 11
quality-adjusted life years (11) 11
smoking (11) 11
costs (10) 10
decision making (10) 10
health policy (10) 10
methods (10) 10
outcomes (10) 10
smoking cessation (10) 10
therapy (10) 10
anticoagulants (9) 9
cost analysis (9) 9
guidelines (9) 9
health care economics and organizations (9) 9
medicine, research & experimental (9) 9
psychiatry (9) 9
surveys and questionnaires (9) 9
tobacco (9) 9
uncertainty (9) 9
aged, 80 and over (8) 8
canada - epidemiology (8) 8
clinical outcomes (8) 8
drug addiction (8) 8
efficacy (8) 8
health care costs (8) 8
health economics (8) 8
oncology (8) 8
pregnancy (8) 8
rare diseases (8) 8
return on investment (8) 8
substance abuse (8) 8
surgery (8) 8
united-states (8) 8
child (7) 7
comparative analysis (7) 7
cost effectiveness (7) 7
drug costs (7) 7
economic aspects (7) 7
economic models (7) 7
electronic books (7) 7
epidemiology (7) 7
equiptmod as a basis for rational investment decisions in tobacco control (7) 7
follow-up studies (7) 7
impact (7) 7
medicine & public health (7) 7
medicine, experimental (7) 7
metaanalysis (7) 7
patients (7) 7
pediatrics (7) 7
physiological aspects (7) 7
prime ministers (7) 7
public health, environmental and occupational health (7) 7
more...
Library Location Library Location
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Thrombosis Research, ISSN 0049-3848, 2016
Journal Article
Journal Article
International Journal of Technology Assessment in Health Care, ISSN 0266-4623, 2018, Volume 34, Issue S1, pp. 53 - 54
Introduction:In March 2017, CADTH released the fourth edition of the Guidelines for the Economic Evaluations of Health Technologies. As part of the update a... 
Journal Article
The New England Journal of Medicine, ISSN 0028-4793, 08/2015, Volume 373, Issue 8, pp. 697 - 704
Journal Article
Lancet, The, ISSN 0140-6736, 2016, Volume 388, pp. S95 - S95
Abstract Background WHO's MPOWER model highlights the importance of supporting smoking cessation. Stop smoking services in England have played a key part in... 
Internal Medicine | Rate of return | Smoking cessation programs | Epidemiology | Analysis | Smoking cessation | Economic models | Tobacco | Return on investment | Smoking | Cancer
Journal Article
Plant and Soil, ISSN 0032-079X, 1/2012, Volume 351, Issue 1, pp. 219 - 236
Journal Article
Value in Health, ISSN 1098-3015, 2013, Volume 16, Issue 4, pp. 498 - 506
Abstract Objectives The primary objective was to assess the cost-effectiveness of new oral anticoagulants compared with warfarin in patients with nonvalvular... 
Internal Medicine | anticoagulants | cost-effectiveness | atrial fibrillation | cardiovascular | warfarin | MORTALITY | MANAGEMENT | ASPIRIN | PROPHYLAXIS | DABIGATRAN ETEXILATE | RISK-FACTOR | HEALTH CARE SCIENCES & SERVICES | HEALTH POLICY & SERVICES | ECONOMICS | Thiophenes - therapeutic use | Pyrazoles - therapeutic use | Cardiovascular Diseases - prevention & control | Humans | Middle Aged | Warfarin - economics | Warfarin - administration & dosage | Warfarin - therapeutic use | Rivaroxaban | Atrial Fibrillation - economics | Benzimidazoles - administration & dosage | Time Factors | beta-Alanine - economics | Aged, 80 and over | Pyridones - economics | beta-Alanine - analogs & derivatives | Morpholines - therapeutic use | Benzimidazoles - therapeutic use | Quality-Adjusted Life Years | Cardiovascular Diseases - etiology | Administration, Oral | Atrial Fibrillation - complications | Anticoagulants - therapeutic use | Stroke - etiology | Hemorrhage - chemically induced | Drug Costs | Markov Chains | Age Factors | Anticoagulants - administration & dosage | Anticoagulants - economics | Thiophenes - administration & dosage | Benzimidazoles - economics | Dabigatran | Morpholines - economics | Pyridones - administration & dosage | Thiophenes - economics | Cardiovascular Diseases - economics | Stroke - prevention & control | Hemorrhage - epidemiology | Morpholines - administration & dosage | Stroke - economics | beta-Alanine - administration & dosage | beta-Alanine - therapeutic use | Pyrazoles - economics | Randomized Controlled Trials as Topic | Pyrazoles - administration & dosage | Cost-Benefit Analysis | Aged | Pyridones - therapeutic use
Journal Article
Journal Article
American Heart Journal, ISSN 0002-8703, 2015, Volume 173, pp. 102 - 107
Journal Article